{"organizations": [], "uuid": "aea3ab9a8d0e27b94cde4fcd0d992b7018e4bd57", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/europe", "section_title": "European Stock Market News | Reuters.com", "url": "https://www.reuters.com/article/flatiron-health-ma-roche-hldg/roche-to-buy-flatiron-health-for-1-9-bln-idUSL4N1Q54SP", "country": "US", "domain_rank": 408, "title": "Roche to buy Flatiron Health for $1.9 bln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.006, "site_type": "news", "published": "2018-02-16T04:38:00.000+02:00", "replies_count": 0, "uuid": "aea3ab9a8d0e27b94cde4fcd0d992b7018e4bd57"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/flatiron-health-ma-roche-hldg/roche-to-buy-flatiron-health-for-1-9-bln-idUSL4N1Q54SP", "ord_in_thread": 0, "title": "Roche to buy Flatiron Health for $1.9 bln", "locations": [], "entities": {"persons": [{"name": "arun koyyur", "sentiment": "none"}, {"name": "akankshita mukhopadhyay", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "flatiron health", "sentiment": "negative"}, {"name": "roche", "sentiment": "negative"}, {"name": "drugmaker roche holding ag", "sentiment": "negative"}, {"name": "flatiron health inc", "sentiment": "none"}, {"name": "flatiron", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - Drugmaker Roche Holding AG said on Thursday it would buy the rest of the privately held oncology data company Flatiron Health Inc for $1.9 billion to speed up development and delivery of breakthrough medicines for cancer patients.\nFlatiron taps into myriad data points on individual cancer cases to help doctors select promising outcomes for their patients. It also stores billing data, doctors' notes and related information.( bit.ly/2EL5OKg )\nRoche already owns 12.6 percent stake in Flatiron. The companies expect the deal to close in the first half of 2018. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Arun Koyyur)\n ", "external_links": ["http://bit.ly/2EL5OKg", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-16T04:38:00.000+02:00", "crawled": "2018-02-15T23:31:39.005+02:00", "highlightTitle": ""}